BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NIHR Biomedical Research Centre: Oxford - ECPv6.15.12.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oxfordbrc.nihr.ac.uk
X-WR-CALDESC:Events for NIHR Biomedical Research Centre: Oxford
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241106T130000
DTEND;TZID=Europe/London:20241106T133000
DTSTAMP:20260514T071303
CREATED:20240815T135930Z
LAST-MODIFIED:20240827T142511Z
UID:20381-1730898000-1730899800@oxfordbrc.nihr.ac.uk
SUMMARY:NIHR Oxford BRC Statistics Hub Lunchtime Seminar: Trial designs for early phase trials
DESCRIPTION:This is the third in a series of eight lunchtime seminars organised by the NIHR Oxford BRC Statistics Hub. Each seminar is 20 minutes long followed by 10 minutes of Q&A\, and will be held via Microsoft Teams. These seminars are open to all in the University of Oxford and Oxford University Hospitals NHS Trust. \n  \nTrial designs for early phase trials \nAlexander Ooms\, OCTRU Senior Statistician \nWednesday 6th November 2024\, 1:00-1:30pm \nEarly phase clinical trials are critical for assessing the safety\, dosage\, and preliminary efficacy of new treatments. This seminar will outline some available designs in Phase I and Phase II settings. \nPhase I trials primarily focus on determining safe dosages and identifying side effects using broad categories of ‘rule-based’ or ‘model-based’ dose escalation methods. \nPhase II trials typically aim to give an early indication of treatment efficacy and further assess safety via single-arm or randomised controlled trials. Adaptive\, occasionally Bayesian\, designs are popular in the early phase setting and some examples of adaptive designs will be discussed. \nNo registration is required. \nClick here to join the session.
URL:https://oxfordbrc.nihr.ac.uk/brc-event/nihr-oxford-brc-statistics-hub-lunchtime-seminar-trial-designs-for-early-phase-trials/
LOCATION:Online
CATEGORIES:Academic Events,Training Events & Courses
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241118T120000
DTEND;TZID=Europe/London:20241118T133000
DTSTAMP:20260514T071303
CREATED:20240220T102727Z
LAST-MODIFIED:20240419T133615Z
UID:20080-1731931200-1731936600@oxfordbrc.nihr.ac.uk
SUMMARY:An introduction to public involvement in research
DESCRIPTION:Are you a researcher who wants to know more about Patient and Public Involvement (PPI)? \nAre you a researcher who is looking for reliable online resources to help get you started with PPI? \nAre you a PPI lead or responsible for PPI in your team or theme looking for  support and information? \nIf so\, NIHR Oxford Biomedical Research Centre together with Oxford University’s Nuffield Department of Primary Care Health Sciences are pleased to invite you to a training session on how to involve patients and the public in your research work. \nJoin us online via Teams. You can sign up here: \nhttps://forms.microsoft.com/r/dpew0R4gE9 \nFor further information please email: \nAngeli.Vaid@ouh.nhs.uk or Polly.Kerr@phc.ox.ac.uk
URL:https://oxfordbrc.nihr.ac.uk/brc-event/involving-patients-and-the-public-in-research-13/
CATEGORIES:PPI Training for Researchers
END:VEVENT
END:VCALENDAR